ArthroVisc 40 is a sterile and non-pyrogenic gel containing concentrated hyaluronic acid with a high molecular weight (approximately 1500 kDa), obtained by bacterial fermentation in a physiological phosphate buffer.
ArthroVisc 40 has been designed to provide an optimal balance between safety and effectiveness of therapy. ArthroVisc40 is for single use only with sterile disposable needles, which are not included in the kit.
Destiny :
Intra-knee injections to treat symptomatic joint pain and improve mobility.
Treatment protocol:
In order to obtain optimal therapeutic effects, 3 injections should be administered at weekly intervals.
Contents of the package:
The package contains 3 syringes, each 2ml containing 40mg (20mg/ml) of hyaluronic acid in phosphate buffered saline.
Contraindications:
Do not administer to patients with known hypersensitivity to one of the ingredients or suffering from a serious disease, e.g. joint infection. It is not recommended for patients suffering from inflammatory diseases of the joints, such as rheumatoid arthritis or Bechterew’s disease. It is not recommended to give hyaluronic acid to children, pregnant or lactating women.
ArthroVisc40 – Class III medical device – CE2797
Reviews
There are no reviews yet